MOUNTAIN VIEW, Calif.,
Jan. 28, 2016 /PRNewswire/
-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of
medication and supply management solutions and analytics software
for healthcare facilities, will hold a conference call
Thursday, February 4, 2016, to
discuss the Company's Fourth Quarter 2015 financial
results.
What:
|
Omnicell Fourth
Quarter 2015 earnings conference call and webcast
|
When:
|
February 4, 2016,
2:30 p.m. PT
|
Who:
|
Randall Lipps,
chairman, president and chief executive officer
Peter Kuipers, chief financial
officer
|
Where:
|
The conference call
can be monitored by dialing 1-800-696-5518 within the U.S
or 1-706-758-4883 for all other
locations. The Conference ID # is 27500940
|
|
The webcast can be
accessed at: http://ir.omnicell.com/events.cfm
|
|
|
How:
|
Link to the Omnicell
website 15 minutes prior to the call to download necessary audio
software
|
Replay:
|
Available starting at
5:30 p.m. PT on February 4, 2016 through 11:59 p.m. PT on
February 18, 2016. Dial 1-855-859-2056
within the U.S. and 1-404-537-3406 for all other locations,
Conference ID # 27500940
|
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been creating
innovative solutions to improve patient care, anywhere it is
delivered. Omnicell is a leading supplier of comprehensive
automation and business analytics software for medication and
supply management across the entire health care continuum—from the
acute care hospital setting, to post-acute skilled nursing and
long-term care facilities, to the patient's home.
Approximately 4,000 customers worldwide use Omnicell automation
and analytics solutions to increase operational efficiency, reduce
medication errors, deliver actionable intelligence and improve
patient safety. The recent acquisition of Aesynt adds distinct
capabilities, particularly in central pharmacy and IV robotics,
creating the broadest medication management product portfolio in
the industry.
The Omnicell SureMed solution provides innovative medication
adherence packaging to help reduce costly hospital readmissions. In
addition, these solutions enable approximately 7,000 institutional
and retail pharmacies worldwide to maintain high accuracy and
quality standards in medication dispensing and administration while
optimizing productivity and controlling costs.
For more information about Omnicell, Inc. please
visit www.omnicell.com.
OMCL-E
Logo -
http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/omnicell-to-release-fourth-quarter-2015-earnings-results-on-february-4th-300211036.html
SOURCE Omnicell, Inc.